Your browser doesn't support javascript.
loading
Utilizing CMP-Sialic Acid Analogs to Unravel Neisseria gonorrhoeae Lipooligosaccharide-Mediated Complement Resistance and Design Novel Therapeutics.
Gulati, Sunita; Schoenhofen, Ian C; Whitfield, Dennis M; Cox, Andrew D; Li, Jianjun; St Michael, Frank; Vinogradov, Evgeny V; Stupak, Jacek; Zheng, Bo; Ohnishi, Makoto; Unemo, Magnus; Lewis, Lisa A; Taylor, Rachel E; Landig, Corinna S; Diaz, Sandra; Reed, George W; Varki, Ajit; Rice, Peter A; Ram, Sanjay.
Afiliação
  • Gulati S; Division of Infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America.
  • Schoenhofen IC; Human Health Therapeutics Portfolio, National Research Council of Canada, Ottawa, Ontario, Canada.
  • Whitfield DM; Human Health Therapeutics Portfolio, National Research Council of Canada, Ottawa, Ontario, Canada.
  • Cox AD; Human Health Therapeutics Portfolio, National Research Council of Canada, Ottawa, Ontario, Canada.
  • Li J; Division of Infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America.
  • St Michael F; Human Health Therapeutics Portfolio, National Research Council of Canada, Ottawa, Ontario, Canada.
  • Vinogradov EV; Human Health Therapeutics Portfolio, National Research Council of Canada, Ottawa, Ontario, Canada.
  • Stupak J; Human Health Therapeutics Portfolio, National Research Council of Canada, Ottawa, Ontario, Canada.
  • Zheng B; Division of Infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America.
  • Ohnishi M; National Institute of Infectious Diseases, Tokyo, Japan.
  • Unemo M; WHO Collaborating Centre for Gonorrhoea and Other STIs, Department of Laboratory Medicine, Microbiology, Örebro University Hospital, Örebro, Sweden.
  • Lewis LA; Division of Infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America.
  • Taylor RE; Biomedical Sciences Graduate Program, Departments of Medicine and Cellular and Molecular Medicine, Glycobiology Research and Training Center, University of California, San Diego, La Jolla, California, United States of America.
  • Landig CS; Biomedical Sciences Graduate Program, Departments of Medicine and Cellular and Molecular Medicine, Glycobiology Research and Training Center, University of California, San Diego, La Jolla, California, United States of America.
  • Diaz S; Biomedical Sciences Graduate Program, Departments of Medicine and Cellular and Molecular Medicine, Glycobiology Research and Training Center, University of California, San Diego, La Jolla, California, United States of America.
  • Reed GW; Preventive and Behavioral Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America.
  • Varki A; Biomedical Sciences Graduate Program, Departments of Medicine and Cellular and Molecular Medicine, Glycobiology Research and Training Center, University of California, San Diego, La Jolla, California, United States of America.
  • Rice PA; Division of Infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America.
  • Ram S; Division of Infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America.
PLoS Pathog ; 11(12): e1005290, 2015 Dec.
Article em En | MEDLINE | ID: mdl-26630657

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ácidos Siálicos / Resistência Microbiana a Medicamentos / Gonorreia / Resistência a Múltiplos Medicamentos / Monofosfato de Citidina Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ácidos Siálicos / Resistência Microbiana a Medicamentos / Gonorreia / Resistência a Múltiplos Medicamentos / Monofosfato de Citidina Idioma: En Ano de publicação: 2015 Tipo de documento: Article